glp 1 agonist for type 1 diabetes GLP-1 receptor agonists are increasingly used to treat 2 and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 Medications for Weight Loss:
Description
GLP-1s on their own have a low risk of hypoglycemia
It addressed the short half-life issue by structural design and delivered strong outcomes, including the first evidence of major clinical benefits (like indications of improved cardiovascular risk factors)
J.AraiY
In medical school, greasy French fries and salted roast beef helped him stay up studying and researching late at night
While the recent phase 3 trial for orforglipron was specifically for type 2 diabetes and not weight loss, the study found that patients who took the drug lost considerable weight
